EID-2 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that increases acetylation of histones, leading to changes in gene expression. EID-2 is known to interact with histone deacetylases; inhibition of these enzymes can prevent EID-2 from exerting its repressive effects on gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that similarly to Trichostatin A, increases histone acetylation and can disrupt EID-2's interaction with HDACs, reducing its transcriptional repression capability. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially impeding EID-2's ability to modify gene transcription through its effects on histone modification. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that increases histone acetylation in cells, which could counteract EID-2's repression of gene transcription by altering the acetylation status of histones. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Selective histone deacetylase inhibitor that targets HDAC class I, potentially disrupting the function of EID-2 which is linked to HDAC activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that can alter gene expression and potentially interfere with EID-2's ability to repress transcription through its effects on histone modification. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor that could disrupt the interaction between EID-2 and HDACs, therefore modulating the transcriptional repression usually mediated by EID-2. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Broad-spectrum HDAC inhibitor that can disrupt multiple HDAC enzymes, potentially affecting EID-2's role in transcriptional repression. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Pan-HDAC inhibitor that may indirectly inhibit EID-2 activity by increasing histone acetylation and disrupting HDAC-mediated transcriptional repression. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
HDAC inhibitor that can impact chromatin remodeling and gene expression, which may interfere with the EID-2-associated repression of transcription. | ||||||